AT
BLUE

Arden Trust’s bluebird bio BLUE Stock Holding History

Arden Trust’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-177
Closed -$105K – 370
2020
Q1 		$105K Buy
+177
New +$172K 0.02% 375
2019
Q3 		– Sell
-129
Closed -$213K – 361
2019
Q2 		$213K Buy
129
+1
+0.8% +$1.73K 0.04% 324
2019
Q1 		$261K Buy
+128
New +$225K 0.04% 301

Other funds holding BLUE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arden Trust's BLUE Position: Q2 2020 in Review

Arden Trust sold out of bluebird bio (BLUE) in Q2 2020, closing a stake of 177 shares — an estimated $105K sold.

Arden Trust first reported a position in BLUE in Q1 2019 and held it in 3 quarters. The position peaked at $261K in Q1 2019. 278 funds tracked by Wall St. Rank hold BLUE as of Q2 2020.

  • Arden Trust reported no remaining bluebird bio position as of Q2 2020 after selling out during the quarter.
  • Arden Trust sold 177 bluebird bio shares in Q2 2020, an estimated $105K.
  • Arden Trust first reported a position in bluebird bio in Q1 2019 and held it in 3 quarters.
  • Arden Trust's bluebird bio position peaked at $261K in Q1 2019.
  • 278 funds tracked by Wall St. Rank held bluebird bio as of Q2 2020.

Based on Arden Trust's 13F filing for Q2 2020, filed 9 Jul 2020.